|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/82 | (2006.01) |
| C12Y 305/01001 | (2013.01) | ||
| C12N 9/82 | (2013.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3642340 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18731853.0 |
| Date of filing the European patent application | 2018-06-21 | |
| (97) | Date of publication of the European application | 2020-04-29 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/066647 |
| Date | 2018-06-21 |
| (87) | Number | WO 2018/234492 |
| Date | 2018-12-27 |
| (30) | Number | Date | Country code |
| 17177237 | 2017-06-21 | EP | |
| 201762523061 P | 2017-06-21 | US | |
| 201715671086 | 2017-08-07 | US |
| (72) |
FRIEDRICH, Lars , DE
O'DONNELL, Anne , IE
|
| (73) |
Jazz Pharmaceuticals Ireland Limited ,
Fifth Floor, Waterloo Exchange Waterloo Road, 4 Dublin,
IE
|
| (54) | MODIFIED L-ASPARAGINASE |
| MODIFIED L-ASPARAGINASE |